Saisei Ventures
Cambridge, Massachusettssaiseiventures.com
Overview
Saisei Ventures is a life science venture capital firm dedicated to building next-generation companies in the healthcare sector. They create ventures that start from bold ideas and empower dynamic entrepreneurs by providing technical, operational, and financial guidance. Saisei's approach combines Western expertise and Japanese innovations to build globally competitive companies that will have the greatest impact on patient lives. They focus on cutting-edge research and emerging technologies, such as cell and gene therapies, with potential to enter new markets and disrupt traditional industries, and generally invest in seed and early opportunities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Optieum Biotechnologies | Jan 2025 | Series A | Lead |
| Kenai Therapeutics | Feb 2024 | Series A | Co-investor |
| Kenai Therapeutics | Jul 2022 | Seed | Lead |
| Craif Inc. | Apr 2022 | Series B | Co-investor |
| CureApp | Mar 2021 | VC Round | Co-investor |
Key People
Hikaru Saito
Partner
Sven Kili
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.